E
Eli Lilly and Company (LLY)
NYQ – Real Time Price. Currency in USD
1306.74
+35.99 (2.83%)
At close: Oct 22, 2026, 3:59 PM EDT
1307.01
+0.27 (0.02%)
After-hours: Oct 22, 2026, 4:14 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
1306.74
+35.99 (2.83%)
At close: Oct 22, 2026, 3:59 PM EDT
1307.01
+0.27 (0.02%)
After-hours: Oct 22, 2026, 4:14 PM EDT
No Data
There are no news for this stock.
Total debt $54.9B significantly exceeds cash reserves ($8.9B), raising financial stability concerns
Total current assets $64.7B exceed Total current liabilities $47.7B, highlighting excellent liquidity
Debt-to-equity ratio (1.6) far exceeds the industry average, reflecting over-leverage
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $7.8B, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.35 | 1.54 | 7.0 | |
| Quick ratio | 1.00 | 1.13 | 7.0 | |
| Debt to Equity | 1.62 | 0.74 | 4.0 | |
| Debt to Assets | 0.39 | 0.30 | 6.0 | |
| Interest coverage | N/A | 8.52 | 10 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 28.54B | 34.12B | 45.04B | 65.18B | 79.67B |
| Gross Profit | 21.91B | 27.04B | 36.62B | 54.13B | 66.44B |
| Operating Income | 8.28B | 10.33B | 17.04B | 29.70B | 39.61B |
| Net Income | 6.24B | 5.24B | 10.59B | 20.64B | 26.71B |
| EBITDA | 9.80B | 11.85B | 18.81B | 31.69B | 41.71B |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | 85.78 | 71.81 | 10 | |
| Operating margin % | 54.22 | 21.39 | 10 | |
| Net margin % | 30.88 | 13.58 | 10 | |
| EBITDA margin % | 56.55 | 26.91 | 10 | |
| Cash flow margin % | 46.53 | 25.54 | 10 | |
| Weighted average score | 10.0 | |||
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| ROA | 21.86 | 8.45 | 10 | |
| ROE | 102.06 | 15.94 | 10 | |
| ROIC | 38.21 | 13.48 | 10 | |
| ROCE | 48.52 | 16.42 | 10 | |
| Weighted average score | 10.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 27.66 | -19.56 | 5.5 |
| Next quarter | 21.57 | 33.56 | 10 |
| Current year | 35.88 | 42.64 | 10 |
| Next year | 15.75 | 36.76 | 9.5 |
| Weighted average score | 8.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 16.04 | -4.06 | -1.98 | 157.96 | 5.3 |
| Y/Y | 47.67 | 25.33 | 32.81 | 458.1 | 10 |
| 3y average | 32.09 | 60.3 | 57.17 | 142.74 | 10 |
| 5y average | 22.49 | 36.58 | 34.35 | 86.51 | 10 |
| Weighted average score | 8.8 | ||||
| NAME | RATIO | INDUSTRY | 5Q TREND | SCORE |
|---|---|---|---|---|
| P/E | 43.18 | 20.80 | 2.8 | |
| PEG (5yr expected) | 1.14 | 2.27 | 6.0 | |
| P/S | 14.40 | 3.22 | 2.8 | |
| P/B | 35.67 | 3.94 | 2.2 | |
| Weighted average score | 3.5 | |||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.55 | 3.01 | 4.0 |
| Payout ratio | 14.65 | 54.89 | 3.0 |
| 5-year dividend growth rate | 15.18 | 5.25 | 10 |
| Years of dividend increase | 12.00 | 2.00 | 8.0 |
| Weighted average score | 6.3 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 8.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Medium | 6.0 |
| Network effect | Medium | 5.0 |
| Economies of scale | Medium | 7.0 |
| Weighted average score | 6.8 | |